Intervention | Mean | 95%LCrI | 95%UCrI |
---|---|---|---|
Probability of response | |||
Imatinib 400 mg daily | 33.6% | Reference category | |
Dasatinib 100 mg daily | 51.1% | 43.9% | 58.5% |
Nilotinib 300 mg twice daily | 58.7% | 49.6% | 67.5% |
Nilotinib 400 mg twice daily | 57.8% | 48.7% | 66.8% |
Imatinib 800 mg daily | 48.1% | 43.1% | 53.1% |
Response Odds Ratios | |||
Imatinib 400 mg daily | N/A | Reference category | |
Dasatinib 100 mg daily | 2.09 | 1.55 | 2.78 |
Nilotinib 300 mg twice daily | 2.87 | 1.95 | 4.11 |
Nilotinib 400 mg twice daily | 2.76 | 1.88 | 3.98 |
Imatinib 800 mg daily | 1.84 | 1.50 | 2.24 |